Sr. Associate – GMQO Audit and Inspection Management (P1-P3-2) at Eli Lilly and Company

Cork, County Cork, Ireland

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, HealthcareIndustries

Requirements

  • Ability to provide support, oversight, and education to quality and business personnel on quality system components, particularly Audits, Inspections, and Notification to Management (NTM)
  • Capability to work closely with the GMQO process owner for monitoring and continuous improvement of Audits and Inspections processes
  • Proficiency in serving as SharePoint Site Administrator for MIM sites, including development and management of cross-functional inspection management infrastructure
  • Skills in administratively and logistically facilitating and managing backroom operations for sponsor inspections and audits hosted by Medicines Quality Organization
  • Competence in managing archiving of audits and inspections data and retrieving documentation from various sources

Responsibilities

  • Provide support, monitoring, and education to quality and business personnel for assigned quality system components, including Audits and Inspections, and Notification to Management (NTM)
  • Work closely with the GMQO process owner for Audits and Inspections to monitor and drive continuous improvement of the process
  • Serve as SharePoint Site Administrator (MIM sites) to develop and manage cross-functional inspection management infrastructure for logistics, preparation/planning, and close-out activities, including tracking sponsor requests and facilitating inspection management response processes
  • Administratively and logistically facilitate and manage backroom for sponsor inspections and audits hosted by Medicines Quality Organization
  • Manage the appropriate archiving of audits and inspections data and retrieval of documentation from various sources

Skills

Audit Management
Inspection Management
Quality Assurance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI